GeneCentric Diagnostics Inc is a leading biotech company based in Durham, NC, specializing in RNA-based diagnostics for precision cancer therapeutics. Their innovative rT I ME Explorer Platform utilizes advanced computational biology informatics to develop robust gene signatures and related diagnostics, enabling the selection of the most effective treatments for cancer patients.
With a focus on unraveling the complexities of the Tumor and Immune MicroEnvironment (T I ME), GeneCentric translates their insights into actionable genomic signatures of drug response and new target identification. Through collaborations with renowned research organizations and commercial reference labs, they accelerate drug development and bring new hope to individuals battling cancer.
Generated from the website